Teva Pharmaceutical Industries Ltd (TEVA)

TEVA (NYSE:Drugs) EQUITY
$61.56
pos +0.61
+1.00%
Today's Range: 60.85 - 61.62 | TEVA Avg Daily Volume: 5,085,900
Last Update: 07/02/15 - 4:03 PM EDT
Volume: 4,721,837
YTD Performance: 5.98%
Open: $60.85
Previous Close: $60.95
52 Week Range: $47.36 - $68.75
Oustanding Shares: 848,000,000
Market Cap: 50,116,800,000
6-Month Chart
TheStreet Ratings Grade for TEVA
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 10 10 13
Moderate Buy 0 0 0 1
Hold 8 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 1 1 0 0
Mean Rec. 2.11 2.05 1.89 1.77
Latest Dividend: 0.29
Latest Dividend Yield: 1.93%
Dividend Ex-Date: 05/15/15
Price Earnings Ratio: 39.66
Price Earnings Comparisons:
TEVA Sector Avg. S&P 500
39.66 18.40 26.19
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-2.54% 13.80% 54.54%
GROWTH 12 Mo 3 Yr CAGR
Revenue -0.20 0.11 0.03
Net Income 142.80 0.10 0.03
EPS 138.50 0.15 0.05
Earnings for TEVA:
EBITDA 6.00B
Revenue 20.27B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.31 $1.27 $5.21 $5.12
Number of Analysts 19 18 22 22
High Estimate $1.40 $1.35 $5.40 $5.46
Low Estimate $1.10 $1.16 $5.10 $4.24
Prior Year $1.23 $1.32 $5.07 $5.21
Growth Rate (Year over Year) 6.12% -3.87% 2.82% -1.79%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Timothy Collins

 | Jul 2, 2015 | 8:00 AM EDT

They've done well considering market had a slightly negative month.

By

Timothy Collins

 | Jun 24, 2015 | 12:23 PM EDT

More names, including some surprises, showing up on bearish scans.

By

Jim Cramer

 | Jun 11, 2015 | 2:18 PM EDT

New companies are coming up with major drugs.

By

Jim Cramer

 | Jun 11, 2015 | 5:40 AM EDT

Two are biotechs and one is in cyber security.

By

Jim Cramer

 | May 27, 2015 | 3:55 PM EDT

Jim Cramer answers your Twitter questions about FireEye (FEYE) and other stocks from the floor of the New York Stock Exchange.

By

Jim Cramer

 | May 21, 2015 | 6:49 PM EDT

Deals coming fast and furious in the best group in town.

By

Jim Cramer

 | May 18, 2015 | 3:24 PM EDT

Acquisitions cut into overabundance of companies.

By

Bryan Ashenberg

 | Apr 30, 2015 | 8:15 AM EDT

Merger rumors abound around salesforce.com.

By

David Peltier

 | Apr 29, 2015 | 4:42 PM EDT

Consumer, health care names lead market lower.

By

Bret Jensen

 | Apr 24, 2015 | 11:00 AM EDT

Watch for small biotechs partnering with bigger firms.

Sorry folks. I received a few queries concerning my earlier note on IMF nullification of t...
It appears that the International Monetary Fund has preemptively nullified the referendum ...
Earlier today we added some IWM puts, this being the 'weakest' performing index this week,...
Forget Greece, forget economic data, forget everything. Just give me my burrito. CMG con...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.